Plasma-Lyte 148 infusion 1litre Viaflo bags

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Sodium chloride; Sodium gluconate; Potassium chloride; Sodium acetate trihydrate; Magnesium chloride hexahydrate

Available from:

Baxter Healthcare Ltd

ATC code:

B05BB01

INN (International Name):

Sodium chloride; Sodium gluconate; Potassium chloride; Sodium acetate trihydrate; Magnesium chloride hexahydrate

Dosage:

5.26gram/1litre ; 5.02gram/1litre ; 370mg/1litre ; 3.68gram/1litre ; 300mg/1litre

Pharmaceutical form:

Infusion

Administration route:

Intravenous

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: ; GTIN: 05413760154695

Summary of Product characteristics

OBJECT 1
PLASMA-LYTE 148 (PH 7.4) SOLUTION FOR INFUSION
Summary of Product Characteristics Updated 26-Apr-2017 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Plasma-Lyte
®
148 (pH 7.4) solution for infusion.
2. Qualitative and quantitative composition
Sodium
Chloride:....................................................................................5.26
g/l
Potassium
Chloride:................................................................................0.37
g/l
Magnesium Chloride
hexahydrate:.........................................................0.30
g/l
Sodium Acetate
trihydrate:.....................................................................3.68
g/l
Sodium
Gluconate:................................................................................5.02
g/l
mmol/l
mEq/l
Na
+
140
140
K
+
5.0
5.0
Mg
++
1.5
3.0
Cl
-
98
98
CH
3
COO
-
(Acetate)
27
27
C
6
H
11
O
7
-
(Gluconate)
23
23
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles
Osmolarity: 295 mOsm/l (approx.)
pH: approx. 7.4 (6.5 to 8.0)
4. Clinical particulars
4.1 Therapeutic indications
Plasma-Lyte 148 (pH 7.4) is indicated:
- for fluid replacement (e.g. after burns, head injury, fracture,
infection, and peritoneal irritation),
- as intraoperative fluid replacement,
- in haemorrhagic shock and clinical conditions requiring rapid blood
transfusions (compatibility with
blood),
- in mild to moderate metabolic acidosis, also in case of lactate
metabolism impairment.
4.2 Posology and method of administration
Posology:
_ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER):_
The dosage and rate of administration depend on the age, weight,
clinical and biological conditions of the
patient and concomitant therapy.
The recommended dosage is: 500 ml to 3 litres / 24 h
_Administration rate:_
The infusion rate is usually 40 mL/kg/24h in adults, the elderly and
adolescents.
When used for intraoperative fluid replacement, normal rate can be
higher and is abou